Daito Pharmaceutical Announces Leadership Changes and New Board Candidates

TOKYO, Jul 10 (Pulse News Wire) – Daito Pharmaceutical CO.,LTD. (4577.T) announced leadership changes and new board candidates effective August 27, 2026.

Yasunobu Otsuka will step down as CEO and take on the role of Chairman. Yukata Kuwahisa, Kenji Otsuga, and Hiroko Kusanoe will join the board as non-audit committee members. Additionally, several executive positions will be restructured, with Nobuhiro Yagi becoming Executive Officer for Business Development and Portfolio Management, and Daishu Takayasu taking on the role of Executive Officer for Human Resources and General Affairs. Kuwahisa brings extensive experience in production management, sales, and strategic planning, while Otsuga has spearheaded key initiatives such as the merger with Daiwa Pharmaceutical Industry and restructuring operations in China.

Kusanoe, an external director, has held senior roles in pharmaceutical distribution and specialty pharma companies. In executive appointments, Yagi will lead Business Development and Portfolio Management, and Takayasu will oversee Human Resources and General Affairs. Other notable changes include Hiroyoshi Kosugi moving to Research and Development, and Masahiko Morii transitioning to Production Management. Kiyo Takami and Norio Kishi will retire from their respective roles.